Table 1 Features of EC patients
Features | EC patients (N = 142) |
|---|---|
Age (years) | |
Mean±SD | 60.1±9.0 |
≥60 years, No. (%) | 73 (51.4) |
Menopausal status, No. (%) | |
Pre-menopause | 29 (20.4) |
Post-menopause | 113 (79.6) |
Diabetes, No. (%) | 33 (23.2) |
Hypertension, No. (%) | 56 (39.4) |
Histological subtype, No. (%) | |
Endometrioid carcinoma G1/G2 | 96 (67.6) |
Endometrioid carcinoma G3 | 15 (10.6) |
Serous endometrial carcinoma | 19 (13.4) |
Clear cell endometrial carcinoma | 12 (8.5) |
Myometrial invasion ≥50%, No. (%) | 55 (38.7) |
Cervical invasion, No. (%) | |
None or epithelial | 106 (74.6) |
Stromal | 36 (25.4) |
Lymphovascular invasion, No. (%) | 36 (25.4) |
FIGO stage, No. (%) | |
I | 88 (62.0) |
II | 18 (12.7) |
III | 23 (16.2) |
IV | 13 (9.2) |
CA125 abnormity, No. (%) | 45 (31.7) |
CA19-9 abnormity, No. (%) | 41 (28.9) |
CEA abnormity, No. (%) | 55 (38.7) |
Adjuvant radiotherapy, No. (%) | 108 (76.1) |
Adjuvant chemotherapy, No. (%) | 46 (32.4) |